Trial Profile
A phase2 trial ofAbraxane Oxaliplatin S1 and Itraconazole for unresectable gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Gimeracil/oteracil/tegafur; Itraconazole; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 01 Feb 2020 Status changed from not yet recruiting to completed.
- 01 Feb 2020 Results published in the Anticancer Research
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology